<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(13)</volume><submitter>Page CK</submitter><pubmed_abstract>The two influenza B virus (FLUBV) lineages have continuously diverged from each other since the 1980s, with recent (post-2015) viruses exhibiting accelerated evolutionary rates. Emerging data from human studies and epidemiological models suggest that increased divergence in contemporary viruses may drive differential cross-protection, where infection with Yamagata lineage viruses provides limited immunity against Victoria lineage viruses. Here, we developed animal models to investigate the mechanisms behind asymmetric cross-protection between contemporary FLUBV lineages. Our results show that contemporary Victoria immunity provides robust cross-protection against the Yamagata lineage, whereas Yamagata immunity offers limited protection against the Victoria lineage. This differential cross-</pubmed_abstract><journal>Science advances</journal><pagination>eadu3344</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11952091</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages.</pubmed_title><pmcid>PMC11952091</pmcid><pubmed_authors>Shepard JD</pubmed_authors><pubmed_authors>Rowe-Haas DK</pubmed_authors><pubmed_authors>Page CK</pubmed_authors><pubmed_authors>Rodriguez AJ</pubmed_authors><pubmed_authors>Tompkins SM</pubmed_authors><pubmed_authors>Akinpelu JY</pubmed_authors><pubmed_authors>Jacob JC</pubmed_authors><pubmed_authors>Hertz T</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Ray SD</pubmed_authors><pubmed_authors>Ferguson JA</pubmed_authors><pubmed_authors>Friedman LM</pubmed_authors><pubmed_authors>Ward AB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages.</name><description>The two influenza B virus (FLUBV) lineages have continuously diverged from each other since the 1980s, with recent (post-2015) viruses exhibiting accelerated evolutionary rates. Emerging data from human studies and epidemiological models suggest that increased divergence in contemporary viruses may drive differential cross-protection, where infection with Yamagata lineage viruses provides limited immunity against Victoria lineage viruses. Here, we developed animal models to investigate the mechanisms behind asymmetric cross-protection between contemporary FLUBV lineages. Our results show that contemporary Victoria immunity provides robust cross-protection against the Yamagata lineage, whereas Yamagata immunity offers limited protection against the Victoria lineage. This differential cross-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-06-25T03:04:35.22Z</modification><creation>2025-06-25T03:04:35.22Z</creation></dates><accession>S-EPMC11952091</accession><cross_references><pubmed>40153499</pubmed><doi>10.1126/sciadv.adu3344</doi></cross_references></HashMap>